Mayo Pujols

Mayo Pujols is an accomplished executive in the biotechnology sector, currently serving as Chief Operating Officer at Castle Creek Biosciences, Inc., focusing on innovative treatments for genetic diseases. Prior experience includes roles as EVP & Chief Technical Officer at Rocket Pharmaceuticals, where the development of curative gene therapies was a key focus, and Chief Executive Officer at Andelyn Biosciences, a contract development and manufacturing organization affiliated with Nationwide Children's Hospital. Additional roles include VP at Novartis, overseeing global cell and gene technical development and manufacturing, and VP of Global CAR-T Operations & Technology at Celgene, where responsibilities included the startup of cGMP facilities and expansion of production capabilities. Mayo Pujols holds a Master of Science in Chemical Engineering & Applied Chemistry from Columbia Engineering and a Bachelor of Engineering in Chemical Engineering from Stevens Institute of Technology.